Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Noad
P Roy

Vaccine

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Vaccine|October 20, 2009
Bluetongue vaccinesR Noad, P Roy
Vaccine|November 6, 2009
Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virusM Stewart, Y Bhatia, T N Athmaran, et al.
Vaccine|July 27, 1999
Efficacy of live adjuvanted mesogenic Newcastle disease vaccine in chickensP Roy, A T Venugopalan, A Koteeswaran
Vaccine|January 1, 1992
Protective efficacy of virus-like particles for bluetongue diseaseP Roy, T French, B J Erasmus
Vaccine|July 1, 1994
Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protectionP Roy, D H Bishop, H LeBlois, et al.
Vaccine|January 31, 2012
Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protectionM Stewart, C I Dovas, E Chatzinasiou, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Vaccine|October 20, 2009
Bluetongue vaccinesR Noad, P Roy
Vaccine|November 6, 2009
Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virusM Stewart, Y Bhatia, T N Athmaran, et al.
Vaccine|July 27, 1999
Efficacy of live adjuvanted mesogenic Newcastle disease vaccine in chickensP Roy, A T Venugopalan, A Koteeswaran
Vaccine|January 1, 1992
Protective efficacy of virus-like particles for bluetongue diseaseP Roy, T French, B J Erasmus
Vaccine|July 1, 1994
Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protectionP Roy, D H Bishop, H LeBlois, et al.
Vaccine|January 31, 2012
Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protectionM Stewart, C I Dovas, E Chatzinasiou, et al.
Pageof 1